DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes

DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes

Background. Recent studies have shown the beneficial effect of dipeptidyl peptidase-4 (DPP4) inhibitor on bone turnover in diabetes mellitus. However, little clinical evidence for DPP4 activity in newly diagnosed type 2 diabetes is available. This study was designed to investigate the relationship b...

Full description

Bibliographic Details
Main Authors:	Min Qiu, Shuheng Zhai, Da Liu
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2020/8874272

Similar Items

Hip Structural Changes and Fracture Risk in Osteopenia and Osteoporosis
by: Meltem Esenyel, et al.
Published: (2011-08-01)

FRACTURE — A RISK FACTOR FOR DEVELOPMENT AND PROGRESSION OF OSTEOPENIA AND OSTEOPOROSIS
by: E A Pobel
Published: (2013-12-01)

Comparative assessment of fracture risk among osteoporosis and osteopenia patients: a cross-sectional study
by: Tomasevic-Todorovic S, et al.
Published: (2018-05-01)

Comparison of the Prevalence of Osteopenia and Osteoporosis in Postmenopausal Women with and without Type 2 Diabetes Mellitus
by: Morteza Aghajanpoor, et al.
Published: (2014-08-01)

Urine Cadmium as a Risk Factor for Osteoporosis and Osteopenia: A Meta-Analysis
by: Dong Li, et al.
Published: (2021-04-01)

Evaluation of quantitative ultrasound in the diagnosis of osteopenia and osteoporosis
by: Frost, Michelle Lorraine
Published: (2000)

Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients
by: Ozlem Altuntas Aydın, et al.
Published: (2013-11-01)

Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients
by: Ozlem Altuntas Aydın, et al.

Prevalence of osteopenia, osteoporosis and their risk factors in the Niterói Family Doctor Program
by: Adilson Mangela-Gomes, et al.
Published: (2019-01-01)

DPP4 in Diabetes
by: Diana eRöhrborn, et al.
Published: (2015-07-01)

Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population
by: Yuhua Wen, et al.
Published: (2021-05-01)

Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
by: Jun Iwamoto, et al.
Published: (2009-09-01)

The Gut Microbiome Is Altered in Postmenopausal Women With Osteoporosis and Osteopenia
by: Elizabeth A Rettedal, et al.
Published: (2021-03-01)

Kinesiophobia and Related Factors in Postmenopausal Women with Osteoporosis and Osteopenia
by: Salim Mısırcı, et al.
Published: (2021-08-01)

Audiovestibular functioning of post-menopausal females with osteoporosis and osteopenia
by: Manisha K. Juneja, et al.
Published: (2021-01-01)

Prevalence of Osteopenia and Osteoporosis in Orthopaedic Outpatients in Southern India
by: Jojin Jose Chitten, et al.
Published: (2018-03-01)

Osteopenia and osteoporosis in people living with HIV: multiprofessional approach
by: Lima AL, et al.
Published: (2011-12-01)

Diversity analysis of gut microbiota in osteoporosis and osteopenia patients
by: Jihan Wang, et al.
Published: (2017-06-01)

Use of Complementary and Alternative Medicine by Osteoporosis and Osteopenia Patients
Published: (2018-01-01)

Markers of Bone Turnover and 25-Hydroxy Vitamin D in Women with Type 2 Diabetes and Newly Diagnosed Osteoporosis
by: Nan Raluca, et al.
Published: (2016-03-01)

Pathophysiology of the risk factors associated with osteoporosis and their correlation to the T-score value in patients with osteopenia and osteoporosis in the United Arab Emirates
by: Nihal A Ibrahim, et al.
Published: (2019-01-01)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
by: Iwamoto J, et al.
Published: (2018-10-01)

Relationships among osteopenia, osteoporosis and locomotive syndrome in menoposal women.
by: Chia-Chia Yeh, et al.
Published: (2018)

Osteopenia and osteoporosis among treatment-experienced people living with HIV
by: Bárbara Marques de Castro Lara, et al.
Published: (2020-07-01)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
by: Chang-Yuan Liu, et al.
Published: (2019-08-01)

A Statistical Approach Regarding the Diagnosis of Osteoporosis and Osteopenia From DXA: Are We Underdiagnosing Osteoporosis?
by: Ronnie Sebro, et al.
Published: (2021-02-01)

Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis
by: Francesco Tovoli, et al.
Published: (2018-12-01)

Osteoporosis and Fragility Fractures in Type 2 Diabetes
by: Iacopo Chiodini, et al.
Published: (2020-01-01)

EFFECT OF RESISTANCE EXERCISES ON HANDGRIP STRENGTH IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA/OSTEOPOROSIS
by: HOLUBIAC I. Ș., et al.
Published: (2020-06-01)

Discovery and Identification of Serum Succinyl‐Proteome for Postmenopausal Women with Osteoporosis and Osteopenia
by: Li‐li Zhang, et al.
Published: (2019-10-01)

Prevalence of osteoporosis and osteopenia in advanced chronic obstructive pulmonary disease patients
by: Parthasarathi Bhattacharyya, et al.
Published: (2011-01-01)

Evaluation of effective factors in decreased bone density in patients with osteoporosis and osteopenia
by: Nasser Aghamohammadzadeh (MD), et al.
Published: (2009-08-01)

Diagnostic value of panoramic indices to predict osteoporosis and osteopenia in postmenopausal women
by: Somayeh Nemati, et al.
Published: (2016-01-01)

Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
by: Ahren B
Published: (2010-03-01)

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
by: Gallwitz B
Published: (2013-01-01)

Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
by: Bo Ahr&eacute;n
Published: (2010-03-01)

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
by: Kishimoto M
Published: (2013-05-01)

Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis
by: Arina Miyoshi, et al.
Published: (2021-07-01)

Osteoporosis, Fractures, and Diabetes
by: Peter Jackuliak, et al.
Published: (2014-01-01)

Development of an mHealth Application for Women Newly Diagnosed with Osteoporosis without Preceding Fractures: A Participatory Design Approach
by: Pernille Ravn Jakobsen, et al.
Published: (2018-02-01)